Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Oxomemazine is a phenothiazine-based histamine H1-receptor blocker with pronounced antimuscarinic activity. Oxomemazine is a selective antagonist of mycotoxins M1 receptors, showing high (Ki=84 nM, M1 receptors) and low (Ki=1.65 μM, M2 receptors) affinity sites 20 times the difference[1]. Oxomemazine is an antihistamine and anticholinergic agent used in studies related to cough studies[2].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
10 mg | In stock | $ 48.00 |
Description | Oxomemazine is a phenothiazine-based histamine H1-receptor blocker with pronounced antimuscarinic activity. Oxomemazine is a selective antagonist of mycotoxins M1 receptors, showing high (Ki=84 nM, M1 receptors) and low (Ki=1.65 μM, M2 receptors) affinity sites 20 times the difference[1]. Oxomemazine is an antihistamine and anticholinergic agent used in studies related to cough studies[2]. |
Targets&IC50 | mGluR1:84 nM (Ki), mGluR2:1.65 μM (Ki) |
Molecular Weight | 330.44 |
Formula | C18H22N2O2S |
CAS No. | 3689-50-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ethanol: 10mg/mL (30.26mM)
DMSO: 30mg/mL (90.79mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
OXOMEMAZINE 3689-50-7 GPCR/G Protein Immunology/Inflammation Neuroscience AChR Histamine Receptor histamine H1-receptor inhibit phenothiazine antimuscarinic muscarinic M1 Inhibitor Metabotropic glutamate receptors cough anticholinergic antihistamine mGluR inhibitor